Concentrix Corporation
CNXC
$46.93
-$0.52-1.10%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.59B | 9.62B | 9.40B | 8.65B | 7.88B |
| Total Other Revenue | -- | 582.68M | 1.11B | 1.47B | 1.85B |
| Total Revenue | 9.59B | 9.62B | 9.40B | 8.65B | 7.88B |
| Cost of Revenue | 6.14B | 6.17B | 6.00B | 5.52B | 5.03B |
| Gross Profit | 3.45B | 3.45B | 3.40B | 3.13B | 2.85B |
| SG&A Expenses | 2.23B | 2.24B | 2.42B | 2.16B | 1.90B |
| Depreciation & Amortization | 458.93M | 458.93M | 214.83M | 214.83M | 214.83M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.83B | 8.87B | 8.64B | 7.89B | 7.14B |
| Operating Income | 756.06M | 746.09M | 761.56M | 753.26M | 743.19M |
| Income Before Tax | 327.24M | 299.27M | 263.48M | 343.87M | 362.71M |
| Income Tax Expenses | 57.87M | 48.06M | 58.42M | 77.81M | 84.64M |
| Earnings from Continuing Operations | 269.37 | 251.22 | 205.05 | 266.06 | 278.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 269.37M | 251.22M | 205.05M | 266.06M | 278.07M |
| EBIT | 756.06M | 746.09M | 761.56M | 753.26M | 743.19M |
| EBITDA | 1.44B | 1.45B | 1.45B | 1.35B | 1.24B |
| EPS Basic | 4.00 | 3.72 | 3.09 | 4.34 | 4.87 |
| Normalized Basic EPS | 4.41 | 4.11 | 3.69 | 4.72 | 5.33 |
| EPS Diluted | 4.00 | 3.72 | 3.09 | 4.33 | 4.85 |
| Normalized Diluted EPS | 4.41 | 4.11 | 3.69 | 4.71 | 5.31 |
| Average Basic Shares Outstanding | 258.28M | 259.91M | 257.44M | 243.84M | 229.75M |
| Average Diluted Shares Outstanding | 258.50M | 260.23M | 257.83M | 244.29M | 230.35M |
| Dividend Per Share | 1.27 | 1.24 | 1.21 | 1.18 | 1.16 |
| Payout Ratio | 31.77% | 33.36% | 39.89% | 28.50% | 25.10% |